Blood Culture Tests Market by Method, Product, Technology, Application, End-user – Global Forecast to 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Blood Culture Tests Market by Method (Automated, Conventional), Product (Consumable, Media, Instruments), Technology (PCR, Microarray, Proteomic), Application (Bacteremia, Mycobacterial), End User (Hospital, Academic Research) – Global Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
The blood culture tests market is projected to reach USD 6.1 billion by 2025 from USD 4.0 billion in 2020, at a CAGR of 8.9%.
Growth in the blood culture tests market can be attributed to increasing number of sepsis cases and high cost of treatment, rising geriatric population, high incidence of bloodstream infections, growth in the demand for rapid diagnostic techniques, and the high prevalence of infectious diseases. However, the high cost of automated instruments and a lack of skilled laboratory technicians are limiting the growth of this market during the forecast period to certain extent.
The consumables segment accounted for the largest market share in 2019.
Based on products, the blood culture tests market is segmented into consumables, instruments, and software and services. Consumables is the largest and fastest-growing segment in 2019. This large share and high growth can be attributed the recurring requirement of consumables as compared to instruments which is the key factor driving the growth of this segment.
The bacteremia applications segment will continue to dominate the blood culture tests market during the forecast period.
Based on application, the blood culture tests market is segmented into bacteremia, fungemia, and mycobacterial detection. Among these application segments, bacteremia accounted for the largest market share in 2019. Also, this segment is also expected to grow at the highest CAGR of during the forecast period. The large share and high growth of this segment is primarily attributed to the increasing number of bloodstream infections and the growing number of sepsis cases worldwide.
The blood culture tests market in the Asia Pacific region is expected to witness the highest growth rate during the forecast period.
Geographically, the blood culture tests market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period, primarily due to the growing geriatric population in Japan and China and the healthcare reforms and government initiatives & investments in several APAC countries.
Market Dynamics
- Growing Number of Sepsis Cases and High Cost of Treatment
- Rising Geriatric Population
- High Incidence of Bloodstream Infections
- Growing Demand for Rapid Diagnostic Techniques
- High Prevalence of Infectious Diseases
- High Cost of Automated Instruments
- Lack of Trained Laboratory Technicians
- Emerging Economies
- Identification of Antibiotic-Resistant Microorganisms
- Market Cannibalization
- Survival of New Entrants
- Laboratory Automation for Increased Efficiency and Accurate Diagnosis
Companies Mentioned
- Anaerobe Systems, Inc.
- Axiom Laboratories
- Becton, Dickinson and Company
- Binder Gmbh
- Biobase Biotech (Jinan) Co. Ltd.
- Biomerieux Sa
- Bruker Corporation
- Bulldog Bio, Inc.
- Carl Zeiss Ag
- Danaher Corporation
- Himedia Laboratories Pvt. Ltd.
- Iridica (A Subsidiary of Abbott Laboratories)
- Luminex Corporation
- Meditech Technologies India Private Limited
- Nikon Corporation
- Opgen, Inc.
- Roche Diagnostics (A Division of F. Hoffmann-La Roche Ltd.)
- Scenker Biological Technology Co. Ltd
- T2 Biosystems, Inc.
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/1qvj2w
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
